Dennis Lal, Ph.D., Cleveland Clinic Genomic Medicine Institute (IMAGE)
Caption
Dennis Lal, Ph.D., of Cleveland Clinic's Genomic Medicine Institute and a research team develop new genetic-based epilepsy risk scores.
Credit
Cleveland Clinic
Usage Restrictions
None
License
Licensed content